Skip to content
  • My Cytovance
  • Events
  • Careers
Cytovance Biologics
  • CDMO Services
    • Overview
    • Microbial
    • Mammalian
    • Pre-Commercial and Commercial
    • Support
  • Your Partner
    • Overview
    • Our Team
    • Facilities
  • Knowledge Library
    • Overview
    • Publications
    • Ingenuity Blog
  • Contact Us
  • My Cytovance
  • Events
  • Careers
Cytovance Biologics
  • CDMO Services
    • Overview
    • Microbial
    • Mammalian
    • Pre-Commercial and Commercial
    • Support
  • Your Partner
    • Overview
    • Our Team
    • Facilities
  • Knowledge Library
    • Overview
    • Publications
    • Ingenuity Blog
  • Contact Us

Ingenuity Blog

Your Molecule Has Met Its Match

Filter by:

Featured

Biomanufacturing Trends Shaping 2026

Biomanufacturing Trends Shaping 2026

2026 is shaping up to be a year of steady progress for biopharmaceutical innovators. While development activity remains strong, sponsors are operating in a challenging environment characterized by increasingly complex modalities, lean resourcing, regulatory uncertainty, and heightened emphasis...
Read Post

Loading...
OPCU July 2024

Outsourced Pharma Capacity Update – July 2024

Cytovance recently appeared on the Outsourced Pharma Large Molecule Capacity Update to share how our available capacity, US-based manufacturing, and...
Read Post
Celltheon Release

Cytovance and Celltheon Partner to Offer a Complete, US-based Platform Solution for mAbs and Difficult-to-Express Proteins

This partnership provides the industry with an integrated solution for customers seeking to outsource cell line development through to cGMP...
Read Post
Advancing Biomanufacturing Excellence Through Artificial Intelligence (AI)

Advancing Biomanufacturing Excellence Through Artificial Intelligence

Discover the role of Artificial Intelligence in revolutionizing biologics manufacturing and learn how Cytovance and partners at the University of...
Read Post
ExcellGene Release

ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture

This partnership provides the industry with cutting-edge options for mammalian-expressed products.OKLAHOMA CITY, Oklahoma, MONTHEY, Switzerland, May 8, 2024 –  ExcellGene...
Read Post
Microbial Strain Development Strategy to Enhance Product Development

Microbial Strain Development Strategy to Enhance Product Development

An efficient microbial strain development strategy stands as the cornerstone of expediting product development timelines and enhancing the overall product...
Read Post
A Brief History of Microbial Biomanufacturing

A Brief History of Microbial Biomanufacturing: Where We’ve Been and Where We Are Going

Harnessing the incredible power of microorganisms to produce a wide array of valuable compounds is as old as recorded civilization...
Read Post
Cytovance Biologics and Alcami Unite to Deliver End-to-End Solutions for Biologics Developers

Cytovance Biologics and Alcami Unite to Deliver End-to-End Solutions for Biologics Developers

This best-of-breed partnership will expedite sterile injectables to patients through the optimized transfer of bulk drug substance to finished drug...
Read Post
Tips for Successfully Scaling from R&D to Manufacturing

5 Tips for Successfully Scaling from R&D to Manufacturing

One of the most critical points in a drug’s journey to patients is the successful scaling up from R&D to...
Read Post
Vectron Release

Large Molecule CDMO, Cytovance Biologics, and Custom Strain Development Expert, Vectron Biosolutions, Partner to Improve Development of Complex Microbial Molecules

This partnership will give the industry new, more efficient options for E. coli-expressed products across many indications of drug development....
Read Post
Axel Schleyer CCO PR

Cytovance Biologics Announces Dr. Axel Schleyer to Expand Footprint and Service Offering as Chief Commercial Officer

OKLAHOMA CITY, Oklahoma, September 27, 2023 – Cytovance Biologics, a leading full-service mammalian and microbial large molecule contract development and...
Read Post
2

Key Considerations for Choosing the Right Microbial CDMO Partner

Demand for outsourcing microbial manufacturing has increased dramatically in recent years and will doubtlessly continue as novel drugs are more...
Read Post
3

Mammalian or Microbial? Considerations When Choosing an Expression System for Your Product

Chinese Hamster Ovary (CHO) cells are considered the gold standard in the production of biologics. Shown here at 100x.  ...
Read Post

End of content

No more pages to load

1 2 … 5 Next »
Subscribe to our Newsletter
Unlock Ingenuity Here

Vision Statement

We believe in a healthier world where every biologic’s path to commercialization is advanced by a development and manufacturing partner that delivers ingenuity end-to-end.

  • CDMO Services
  • Your Partner
  • Knowledge Library
  • Careers
  • Contact Us

© 2026 Cytovance Biologics